Inverse association between circulating levels of soluble receptor for advanced glycation end-products and coronary plaque burden

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 10, 2012, Pages 941-948

  Basta, Giuseppina ^a   Del Turco, Serena ^a   Navarra, Teresa ^a   Mazzarisi, Alessandro ^a   Cocci, Franca ^b   Coceani, Michele ^b   Bianchi, Massimiliano ^b   Schlueter, Mathis ^b   Marraccini, Paolo ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

Author keywords

64 slice computed tomography angiography; Coronary artery disease; Soluble receptor for advanced glycation endproducts

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE;

AGED; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; SOLUBILITY; VASCULAR CALCIFICATION;

EID: 84869232307     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.10561     Document Type: Article

References (20)

1. Bopp C, Bierhaus A, Hofer S, Bouchon A, Nawroth PP, Martin E, Weigand MA: Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit Care, 2008; 12: 201
2. Basta G: Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis, 2008; 196: 9-21
3. Yan SF, D'Agati V, Schmidt AM, Ramasamy R: Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging. Curr Mol Med, 2007; 7: 699-710
4. Santilli F, Vazzana N, Bucciarelli LG, Davi G: Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr Med Chem, 2009; 16: 940-952
5. Ramasamy R, Yan SF, Schmidt AM: RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts. J Leukoc Biol, 2009; 86: 505-512
6. Falcone C, Emanuele E, D'Angelo A, Buzzi MP, Belvito C, Cuccia M, Geroldi D: Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol, 2005; 25: 1032-1037
7. Chiang KH, Huang PH, Huang SS, Wu TC, Chen JW, Lin SJ: Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients. Coron Artery Dis, 2009; 20: 267-273
8. Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, Emoto M, Shoji T, Tamei H, Matsuki H, Sakurai S, Yamamoto Y, Yonekura H, Watanabe T, Yamamoto H, Nishizawa Y: Plasma level of endogenous secretory RAGE is associated with components of the meta- bolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol, 2005; 25: 2587-2593
9. Basta G, Leonardis D, Mallamaci F, Cutrupi S, Pizzini P, Gaetano L, Tripepi R, Tripepi G, De Caterina R, Zoccali C: Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease. Kidney Int, 2010; 77: 225-231
10. Hausleiter J, Meyer T, Hadamitzky M, Kastrati A, Martinoff S, Schomig A: Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease. J Am Coll Cardiol, 2006; 48: 312-318
11. Jinzaki M, Yamada M, Sato K, Tanami Y, Anzai T, Sasaki K, Kuribayashi S: Overview image of the lumen and vessel wall in coronary CT angiography. Circ J, 2008; 72: 671-673
12. Matsunaga E, Takaya N, Yokoyama T, Akimoto Y, Miyauchi K, Daida H: Relationship between coronary artery wall thickness measured by 64-slice multidetector computed tomography and cardiovascular risk factors. Circ J, 2009; 73: 681-685
13. Achenbach S, Moselewski F, Ropers D, Ferencik M, Hoffmann U, MacNeill B, Pohle K, Baum U, Anders K, Jang IK, Daniel WG, Brady TJ: Detection of calcified and noncalcified coronary atherosclerotic plaque by contrastenhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound. Circulation, 2004; 109: 14-17
14. Hendel RC, Patel MR, Kramer CM, Poon M, Hendel RC, Carr JC, Gerstad NA, Gillam LD, Hodgson JM, Kim RJ, Kramer CM, Lesser JR, Martin ET, Messer JV, Redberg RF, Rubin GD, Rumsfeld JS, Taylor AJ, Weigold WG, Woodard PK, Brindis RG, Hendel RC, Douglas PS, Peterson ED, Wolk MJ, Allen JM, Patel MR: ACCF/ ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol, 2006; 48: 1475-1497
15. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H,Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation, 1998; 97: 1837-1847
16. Arai K, Ishii H, Amano T, Uetani T, Nanki M, Marui N, Kato M, Yokoi K, Ando H, Kumagai S, Harada K, Yoshikawa D, Ohshima S, Matsubara T, Murohara T: Volumetric analysis of coronary plaque characterization in patients with metabolic syndrome using 64-slice multi-detector computed tomography. Circ J, 2010; 74: 2146-2151
17. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW: A definition of advanced types of atheroscleact 1220 rotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation, 1995; 92: 1355-1374
18. Hoffmann U, Moselewski F, Nieman K, Jang IK, Ferencik M, Rahman AM, Cury RC, Abbara S, Joneidi-Jafari H, Achenbach S, Brady TJ: Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. J Am Coll Cardiol, 2006; 47: 1655-1662
19. Towler DA: Vascular calcification: it's all the RAGE! Arterioscler Thromb Vasc Biol, 2011; 31: 237-239
20. Lindsey JB, de Lemos JA, Cipollone F, Ayers CR, Rohatgi A, Morrow DA, Khera A, McGuire DK: Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study. Diabetes Care, 2009; 32: 1218-1220